Search Everything in One Place

Explore the web, images, videos, news, and more – all in one place.

Finance

Dyne Therapeutics launches $300M stock offering; shares fall 14% in after hours

BJ’s Wholesale Club Non-GAAP EPS of $0.85 in-line, revenue of $4.72B misses by $90M
Dyne Therapeutics launches $300M stock offering; shares fall 14% in after hours

Dyne Therapeutics (DYN) announced on Tuesday that it has commenced an underwritten public offering of $300M of its common stock. The underwriters have a 30-day option to purchase up to an additional $45M of common stock, bringing the total potential offering size to $345M. The offering is subject to market conditions, and the company said there is...

  • Dyne Therapeutics (DYN) announced on Tuesday that it has commenced an underwritten public offering of $300M of its common stock.
  • The underwriters have a 30-day option to purchase up to an additional $45M of common stock, bringing the total potential offering size to $345M.
  • The offering is subject to market conditions, and the company said there is no assurance on the timing, completion, or final size of the offering.
  • The DYN stock traded ~14% lower at ~$20.50 in the after-hours trading.
Read full story on Seeking Alpha

Related News

More stories you might be interested in.

Top